Navigation Links
Genome-wide mouse study yields link to human leukemia

Thanks to a handful of very special mice, scientists have discovered a new tumor suppressor gene and a unique chemical signature implicated in the development of human leukemia, findings that open up a "treasure box" of opportunity and possibility, study authors say.

Researchers in The Ohio State University Comprehensive Cancer Center bred a type of mouse that develops acute lymphoblastic leukemia (ALL). The mouse first goes through a pre-leukemic stage marked by rapidly expanding T cells and natural killer cells, both major components of the immune system.

In comparing the mice in the pre-leukemic stage and those with ALL with normal mice, researchers found that methylation, a chemical process that adds methyl molecules to DNA, silenced a number of genes ?but only in the mice with full-blown ALL.

Further tests revealed that the methylation pattern in the mice with leukemia is strikingly similar to the pattern of methylation in human leukemia.

In the process, the researchers also identified a new gene that when methylated, appears to interrupt normal cell death, a process called apoptosis.

"It's given us a whole new way to look at and possibly treat leukemia," says Michael Caligiuri, director of the OSU Comprehensive Cancer Center (OSUCCC) and senior co-author of the study. "It's also validated our mouse model as a good predictor of what happens in the development of human disease," he added.

The findings appear in Nature Genetics online at http://www.nature.com/ng/.

"This is the first time anyone has examined methylation in leukemia on a genome-wide basis in a mouse, and the findings offer important implications for patient care, since we know that methylation, which alters gene function, can be reversed," says Christoph Plass, senior co-author and a member of the OSUCCC's Molecular Biology and Cancer Genetics and Experimental Therapeutics Programs.

While it was Caligiuri's laboratory that designed the
'"/>

Source:Ohio State University


Page: 1 2 3

Related biology news :

1. Man and mouse share genome structures
2. Report that delayed motherhood decreases life expectancy of mouse offspring
3. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
4. Stem cells in bone marrow replenish mouse ovaries
5. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
6. Researchers extend mouse lifespan by protecting against free radicals
7. Gene therapy advance treats hemophilia in mouse models
8. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
9. New technique could alter field of mouse genetics
10. Building a better mouse model of lung cancer: FHIT counts
11. Chemical compound inhibits tumor growth, size in new mouse study
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genome wide mouse study yields link human leukemia

(Date:2/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announced ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... groundbreaking payment method. Payment accounts may be selected via ... accessed if both the speech (the word associated with ...
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... in cargo screening significantly extend the time of goods ... and rapid screening and detection systems. At the same ... for efficient access control systems in ports and entry ... , New analysis from Frost & Sullivan ( ...
... YORK, July 7 Reportlinker.com just added a new ... World Solid-State, Fiber, Gas and Dye Lasers ... http://www.reportlinker.com/p0119491/World-Solid-State-FiberGas-and-Dye-Lasers-Market.html?utm_source=PRNWire&utm_medium=PR&utm_campaign=PRNWire ... for Solid-State, Fiber, Gas and Dye Lasers in US$ ...
... WASHINGTON DC, July 9 Precise,Biometrics has been awarded orders ... and software to the US Government, as a step in,continued ... and the order will be delivered and invoiced,before end of ... News Release, please click: , ...
Cached Biology News:Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan 2Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan 3New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 2New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 3New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 4New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 5New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 6New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 7New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 8New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 9New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 10New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 11New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 12New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 13New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 14New Report Just Published: World Solid-State, Fiber, Gas and Dye Lasers Market Report 15US Government Places 6,1 Million USD Orders Related to Precise Match-on-Card(TM) for Cyber Security Programs 2
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Cytokinetics, Incorporated ... on February 28 with patients and health care advocates ... for Rare Disease Day®. Rare Disease Day is ... calling attention to the special challenges faced by patients ... , “Cytokinetics is proud to stand alongside patients and ...
(Date:2/26/2015)... Feb. 26, 2015  23andMe, the leading personal genetics ... as Privacy Officer and Corporate Counsel. Black brings ... laws as well as health care regulations. As a ... be responsible for reviewing, updating and enhancing the company,s ... and abroad. She joined the company January 5, 2015 ...
(Date:2/26/2015)... LAUDERDALE, Fla. , Feb. 26, 2015 ... discussed growth priorities driven by key research advancements and ... segments at today,s Bank of America Merrill Lynch 2015 ... met the challenge of building grain supplies the last ... to continue at the pace of the last decade, ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... gas emissions, DECATUR, Ill., Jan. 4 ... Midwest Geological Sequestration Consortium (MGSC),and the Illinois State ... on a carbon sequestration project. The project will,involve ... ADM,s ethanol plant,in Decatur, Illinois. In this project, ...
... AutoGenomics announced today,that the Company has been invited ... which is being held January 7-10, 2008 at,the Westin ... conference,Fareed Kureshy President and Chief Executive Officer will provide ... January 8, 2008., About JPMorgan 26th Annual Healthcare ...
... THRM ), a leader in non-invasive tissue ... will present at the 10th Annual Needham &,Company ... York City. The,Company,s presentation is scheduled for Friday, ... J. Fanning, Chairman, President and Chief,Executive Officer, will ...
Cached Biology Technology:ADM, MGSC and ISGS Announce Carbon Sequestration Project 2ADM, MGSC and ISGS Announce Carbon Sequestration Project 3
... PRODUCT SPECIFICATIONS Form: White powder Assay: 1.5 - 2.0 Bleomycin ... 6.0 Loss On Drying: less than or equal to 6.0% ... A 2 : 55 - 70% B 2 : 25 ... or equal to 90% B 4 : less than or ...
... High Vacuum pumps deliver critical performance for ... ballast control optimizes pump performance to suit ... allows for convenient checking of proper oil ... of pumps is designed to work with ...
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
Biology Products: